“Briteseed’s Burgeoning Smart Surgical Tools Stop Unsafe Bleeding.” Chicago-based Briteseed LLC is developing the next generation of smart surgical tools that can provide visual, anatomical information to surgeons in real-time. In addition to improving patient outcomes, Jonathan believes Briteseed could offer significant cost savings for payors and providers impacted by non-reimbursable costs. In this interview, CEO Jonathan Gunn, Phd, JD, talks about his early inspiration and his experiences in co-founding the company, his current priorities, and what’s next for Briteseed.
“Conavi: Completing the Picture for Intravascular Imaging.” Toronto-based commercial-stage medical device company Conavi Medical is developing image guidance technologies for use in minimally invasive cardiovascular procedures and is on a mission “to make procedures that are established or emerging safer, faster, and with better outcomes.” In this interview, Brian talks about his inspiration and early experiences in founding the company, his current priorities, and what’s next for Conavi.
“From Railroads to Robots: The Story Behind Deneb Medical.” Spain-based start-up Deneb Medical is developing a surgical robot for selective tissue ablation called CoBot, which the Co-founders believe will directly reduce the risk of unintended damage to critical anatomical structures. In this candid interview, the Co-founders talk about their inspiration and early experiences in founding the company, their current priorities, and what’s next.
In this week’s post, we continue our look at executives working to make an impact in surgical robotics, including David McNally, CEO of Titan Medical, and Christopher Prentice, CCO at Mazor Robotics. Also, we note a few observations from last week’s annual Society of Robotic Surgery (SRS) conference in Stockholm, where key executives from all the major robotics companies assembled to discuss the current status and future of the field. [Read Part 1]